Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection

The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.

By: C. Michael White, University of Connecticut, The Conversation

Outlets: The Conversation

Published: April 7, 2026

Words: 1,072

Last Updated: 3 months, 3 weeks ago

Body Text Preview

By C. Michael White, University of Connecticut

A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – and thus could not prove – whether the products were sterile.

These products are sold under several names at major retailers across the country. The company, K.C. Pharmaceuticals, initiated the recall on March 3, 2026.

I am a clinical pharmacologist and pharmacist who has …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us